Results 151 to 160 of about 5,464 (192)

Abciximab reduces mortality in diabetics following percutaneous coronary intervention

Journal of the American College of Cardiology, 2000
OBJECTIVESWe sought to determine whether abciximab therapy at the time of percutaneous coronary intervention (PCI) would favorably affect one-year mortality in patients with diabetes.BACKGROUNDDiabetics are known to have increased late mortality ...
Deepak L Bhatt, Steven P Marso, A Michael Lincoff   +2 more
exaly   +2 more sources

A randomized trial comparing primary infarct artery stenting with or without abciximab in acute myocardial infarction

Journal of the American College of Cardiology, 2003
ObjectivesWe sought to evaluate the efficacy of abciximab as adjunctive therapy to routine infarct-related artery (IRA) stenting.BackgroundThe impact of abciximab on the efficacy of myocardial reperfusion and the outcome of patients with acute myocardial
David Antoniucci, Angela Migliorini, Guido Parodi   +2 more
exaly   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

Abciximab

Reactions Weekly, 2002
Deepak Bhatt, A Lincoff
  +5 more sources

Abciximab

Reactions Weekly, 2018
  +5 more sources

Abciximab

Reactions Weekly, 2013
  +4 more sources

Abciximab

Reactions Weekly, 2016
  +4 more sources

Abciximab

Reactions Weekly, 2003
  +4 more sources

Abciximab

Reactions Weekly, 2011
  +4 more sources

Abciximab

Reactions Weekly, 1999
openaire   +2 more sources

Abciximab

Reactions Weekly, 2017
  +4 more sources